$123 Million is the total value of Kopp Family Office, LLC's 14 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Sell | Horizon Therapeutics Public Limited Company | $33,578,000 | -22.6% | 542,543 | -0.3% | 27.33% | -10.3% |
| IEFA | Sell | ISHARES TRcore msci eafe | $20,537,000 | -10.7% | 389,922 | -0.2% | 16.72% | +3.5% |
| JAMF | Buy | JAMF HOLDING CORP | $13,815,000 | -10.2% | 623,443 | +0.4% | 11.24% | +4.0% |
| NEO | Sell | NeoGenomics Inc. | $13,252,000 | +0.7% | 1,539,113 | -4.7% | 10.79% | +16.6% |
| FIVN | Buy | Five9, Inc. | $13,135,000 | -17.4% | 175,178 | +0.4% | 10.69% | -4.3% |
| IEMG | Sell | ISHARES TRcore msci emkt | $13,072,000 | -12.6% | 304,145 | -0.2% | 10.64% | +1.3% |
| VCEL | Sell | Vericel Corporation | $12,829,000 | -7.9% | 552,963 | -0.0% | 10.44% | +6.8% |
| MITK | Buy | MITEK SYS INC | $2,329,000 | +0.4% | 254,255 | +1.3% | 1.90% | +16.3% |
| ISTB | ISHARES TRcore 1 5 yr usd | $103,000 | -2.8% | 2,228 | 0.0% | 0.08% | +13.5% | |
| IVV | ISHARES TRcore s&p500 etf | $84,000 | -5.6% | 234 | 0.0% | 0.07% | +7.9% | |
| IAGG | ISHARES TRcore intl aggr | $42,000 | -2.3% | 862 | 0.0% | 0.03% | +13.3% | |
| IMTB | ISHARES TRcr 5 10 yr etf | $35,000 | -5.4% | 834 | 0.0% | 0.03% | +7.7% | |
| IJH | ISHARES TRcore s&p mcp etf | $27,000 | -3.6% | 122 | 0.0% | 0.02% | +10.0% | |
| IJR | ISHARES TRcore s&p scp etf | $15,000 | -6.2% | 169 | 0.0% | 0.01% | +9.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NeoGenomics Inc. | 16 | Q3 2023 | 90.1% |
| Vericel Corporation | 16 | Q3 2023 | 14.5% |
| Five9, Inc. | 16 | Q3 2023 | 11.2% |
| ISHARES TR | 13 | Q3 2023 | 16.7% |
| ISHARES TR | 13 | Q3 2023 | 10.6% |
| ISHARES TR | 13 | Q3 2023 | 0.1% |
| ISHARES TR | 13 | Q3 2023 | 0.1% |
| ISHARES TR | 13 | Q3 2023 | 0.0% |
| ISHARES TR | 13 | Q3 2023 | 0.0% |
| ISHARES TR | 13 | Q3 2023 | 0.0% |
View Kopp Family Office, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| RTI Surgical Holdings, Inc. | July 07, 2020 | ? | ? |
| NEOGENOMICS INC | January 07, 2020 | 4,844,625 | 4.6% |
| OCLARO, INC. | January 04, 2019 | ? | ? |
| SUPERCONDUCTOR TECHNOLOGIES INC | October 05, 2018 | ? | ? |
View Kopp Family Office, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-16 |
View Kopp Family Office, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.